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Abstract
Objective: To study whether increased body mass index is associated with altered expression of 
extracellular vesicle microRNAs (EV-linked miRNAs) in human follicular fluid.
Design: A cross-sectional study
Setting: Tertiary, university-affiliated center
Patients: One hundred and thirty-three women undergoing in vitro fertilization (IVF) were 
recruited between January 2014 and August 2016.
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Interventions: None
Main Outcome Measures: EV-linked miRNAs were isolated from follicular fluid and their 
expression profiles were measured using the TaqMan Open Array® Human miRNA panel. EV-
linked miRNAs were globally normalized and inverse-normal transformed. Associations between 
BMI and EV-linked miRNA outcomes were analyzed using multi-variate linear regression and 
principal component analysis.
Result(s): Eighteen EV-linked miRNAs were associated with an increase in BMI after adjusting 
for age, ethnicity, smoking status and batch effects. Hsa-miR-328 remained significant after false-
discovery rate adjustments. Principal component analyses identified the first principal component 
to account for 40% of the variation in our EV-linked miRNA dataset and adjusted linear regression 
found the first principal component was significantly associated with BMI after multiple testing 
adjustments. Using Kyoto Encyclopedia of Genes and Genomes enrichment analyses, we 
predicted gene targets of EV-linked miRNA in silico and identified PI3K-Akt signaling, ECM-
receptor interaction, focal adhesion, FoxO signaling, and oocyte meiosis pathways.
Conclusions: These results show that a one-unit increase in BMI is associated with altered 
follicular fluid expression of EV-linked miRNAs that may influence follicular and oocyte 
developmental pathways. Our findings provide potential insight into a mechanistic explanation for 
the reduced fertility rates associated with increased BMI.
Capsule:
An increase in BMI was associated with EV-linked miRNA expression in human follicular fluid.
Keywords
IVF; microRNAs; extracellular vesicles; BMI
Introduction:
Human infertility is influenced by a broad range of physical, hormonal, genetic and 
environmental stressors (1). Despite enormous advances in the technical aspects of IVF, the 
success rates of the procedure remain relatively low. Whereas much has been published 
about non-modifiable factors associated with outcomes of IVF such as female age, fertility 
diagnosis, and ovarian reserve, less attention has been devoted to modifiable behavioral risk 
factors, such as body mass index (BMI) that may influence IVF outcomes (2-4).
Studies have shown that an increased BMI and obesity alter follicular development, oocyte 
maturation, and reduced numbers of oocytes retrieved (5-9). Women with a BMI ≥ 25 kg/m2 
undergoing IVF have a significantly reduced chance of a clinical pregnancy compared to 
women with BMI < 25 kg/m2 (10-12). Despite the ample epidemiologic evidence, the 
molecular mechanisms underlying how increased BMI contributes to infertility are still 
unknown.
The ovarian follicle houses the oocyte itself and as it matures, cellular differentiation occurs, 
creating cellular layers of thecal, mural granulosa, and cumulus cells. Theca and granulosa 
cells create the membrane of the follicle itself, while cumulus cells encapsulate the oocyte 
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(13, 14). Follicular fluid is a crucial microenvironment for the developing oocytes, 
containing hormones, metabolites, ions, proteins, and various biological structures including 
non-coding RNAs and extracellular vesicles (EVs) (14-21). EVs, membrane enclosed 
structures (22), have been identified as a means for intercellular communication between the 
granulosa cells and oocyte in the follicular fluid (15). They are nanosized (30-700 nm in 
diameter) and can contain numerous molecules involved in cell signaling and cell to cell 
communication, including microRNAs, which are short non-coding RNA molecules 
(approximately 22 nucleotides long) (23). MicroRNAs are short, non-coding RNA 
molecules that can post-transcriptionally regulate gene expression (24-26) and can be free-
floating or packaged in extracellular vesicles (EV-linked miRNAs). Extracellular vesicles 
(exosomes, micro-vesicles, and other membrane-bound vesicles) have been detected in 
almost every biofluid, including follicular fluid (22), and can act as a vehicle carrying 
proteins, messenger RNAs (mRNAs), and microRNAs (miRNAs) (27). These extracellular 
vesicle linked microRNAs (EV-linked miRNAs) can be encapsulated within the EV itself, 
but also associated with the EV extracellularly (28). These EV-linked miRNAs can influence 
gene expression and may be important for follicular signaling (15, 29, 30).
Several studies to date have reported possible associations between BMI and EV-linked 
miRNA profiles either in adipocytes or serum linking some of these EV-linked miRNAs with 
pathways of inflammation and insulin resistance (31-34). To the best of our knowledge, no 
study has examined associations between BMI and EV-linked miRNAs found in follicular 
fluid. Investigating EV-linked miRNAs in follicular fluid might help elucidate the 
mechanisms and pathways by which these modified risk factors that can impact fertility. 
Therefore, this study was aimed to investigate the effects of BMI with EV-linked miRNA 
expression isolated from follicular fluid in women undergoing IVF treatment.
Materials & Methods:
Ethics
This study was approved by Sheba Medical Center IRB in accordance with the Declaration 
of Helsinki (35). All participants provided written informed consent upon enrollment.
Study Population:
Between January 2014 and August 2016, women undergoing IVF were recruited in a tertiary 
care university-affiliated hospital. Eligibility criteria were women aged 19 to 38 years old, 
undergoing their 1st to 6th IVF attempt with a basal FSH less than 10 IU. To avoid potential 
confounding by the stimulation regimen or fertility diagnosis, we enrolled only women that 
were treated using GnRH antagonist protocol as well as women undergoing IVF due to 
unexplained infertility, mild male factors or women undergoing IVF for pre-gestational 
diagnosis of autosomal recessive disorders. We excluded those with a diagnosis of 
polycystic ovarian syndrome (PCOS), endometriosis or poor responders according to 
Bologna criteria (36) which might impair oocyte quality. All women contributed a single 
IVF cycle.
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Exposure Assessment:
Participant’s height and weight were measured at the beginning of the IVF cycle and were 
used to calculate body mass index (BMI, kg/m2). Body mass index was calculated by 
dividing the weight (kg) of a person with the square of their height (m2).
Outcome Assessment:
RNA extraction from follicular fluid: Follicular fluid (otherwise discarded material) 
was collected during oocyte retrieval from a single follicle ≥18 mm, per patient and 
centrifuged at 1500×g for 15 min. FF was aliquoted to 0.5 ml tubes So that the volumes of 
FF that were analyzed were equivalent among patients. Samples were pre-cleaned using a 
0.80 um pore-size polyethersulfone filter (StericupRVP, Merck Millipore) to remove larger 
proteins and debris and aliquoted into 500 uL for immediate storage at −80°C (37). Only 
mature (MII) oocytes were examined for RNA analysis. Methods for RNA extraction from 
biological fluids have been previously described (38). In short, samples were thawed, 
centrifuged for 15 min at 1200 × g at room temperature and then centrifuged three times at 
1000, 2000, and 3000 × g, respectively, for 15 min at 4°C Following this steps, samples were 
ultracentrifuged (Beckman Coulter Optima-MAX-XP) at 110,000 × g for 75 min at 4°C for 
the extraction of EV, as ultracentrifugation is considered the standard according to 
International Society for Extracellular Vesicle recommendations (28, 39). The pellets 
obtained were kept at −80°C until use. EV-linked miRNAs were extracted from the 
ultracentrifuged pellets using the miRNAeasy Kit and RNeasy CleanUp Kit per the 
manufacturer (Qiagen, Valencia, CA, USA). The final purified EV-linked miRNA-enriched 
RNA was eluted into 20 uL of RNAse-free water and stored at −80°C until further use. This 
protocol has been tested and samples have been examined by both Nanosight and Flow 
Cytometry for CD63 (an EV-specific marker) (results unpublished).
Expression analysis of EV-linked miRNAs in follicular fluid: We screened for 754 
microRNAs using the TaqMan Open Array® system. We obtained 758 Crt values for each 
follicular fluid sample, which included 754 unique miRNAs and four internal controls (ath-
miR159a, RNU48, RNU44 and U6). Methods of Real-Time Quantitative Polymerase Chain 
Reaction (RT-qPCR) for screening EV-linked miRNAs using the microRNA array in 
biological fluids are published elsewhere (38). QuantStudio™ 12K Flex is a fixed-content 
panel containing validated human TaqMan® MicroRNA Assays derived from Sanger 
miRBase release v.14. All 754 assays have been functionally validated with miRNA 
artificial templates. The panel is specifically designed to provide specificity for only the 
mature miRNA targets. TaqMan MicroRNA Assays (spotted in the panel) incorporate a 
target-specific stem–loop reverse transcription primer allowing to work despite the short 
length of mature miRNAs (~22 nucleotides) which prohibits conventional design of primers. 
Briefly, we prepared 3.3 uL of each RNA sample and then reverse-transcribed to cDNA 
(complementary DNA) and pre-amplified. Pre-amplified samples were mixed with the 
TaqMan Open Array® Real Time PCR Master Mix (Life Technologies, Foster City, CA) and 
loaded onto a TaqMan™ OpenArray® Human miRNA panel with the QuantStudio™ 
AccuFill System Robot (Life Technologies, Foster City, CA). RT-qPCR was performed on 
the QuantStudio™ 12K Flex Real-Time PCR System with the OpenArray® Platform 
[QS12KFLEX] (Life Technologies, Carlsbad, CA) according to the manufacturer’s 
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instructions. Expression levels were calculated in relative cycle threshold values (Crt), 
estimating the amplification cycle at which the fluorescence levels for each of the analyzed 
EV-linked miRNAs exceed the background fluorescence threshold (40).
Covariate Assessment:
Participant’s age, number of previous IVF attempts, and number of oocytes retrieved at the 
start of IVF cycle were extracted from participant’s medical charts. Cigarette smoking status 
was determined by a questionnaire in which participants were asked about cigarette smoking 
history and intensity. Smoking status was categorized as never smokers, former smokers, 
and current smokers. Those who self-identified as former smokers stopped smoking prior to 
the beginning of their IVF cycle. Follicular fluid samples were analyzed for EV-linked 
miRNAs in two batches and in our subsequent statistical analyses we controlled for batch 
(batch 1 vs batch 2).
Statistical Analysis:
Descriptive statistics and normalization of EV-linked miRNAs: Thermo Fisher 
Cloud Relative Quantification software was used to extract the EV-linked miRNA qPCR 
data. To ensure accuracy of in our normalization methods of the EV-linked miRNAs, we ran 
algorithms to identify the best normalization strategy. We first applied the NormFinder and 
geNorm algorithms to select the best normalization strategy among global mean (arithmetic 
and geometric), RNU48, RNU6, or the average of the four miRNAs with the lowest standard 
deviation (SD) among subjects. Based on these algorithms, we found that global mean was 
the best method to normalize the data. EV-linked miRNAs data was normalized using the 
global mean (GM) method (ΔCrt_EV-linked miRNAi = (Crt_EV-linked miRNAi – 
Crt_EV-linked miRNAi_global_mean)) (38). All the EV-linked miRNA with a Crt value > 28 
and/or an amplification score ≤ 1.24 were identified as unexpressed. For the global mean, we 
coded all those EV-linked miRNAs that were unexpressed as 28 as suggested by Pergoli et 
al. (41). We calculated the delta Crt based on the global mean across all the miRNAs within 
that subject and dividing it by the total miRNAs (N=754). All subsequent analyses were 
performed exclusively on those EV-linked miRNAs that had expressed values, which were 
detected in at least 15% of our samples, based on the histogram distribution of the percent 
detected in our samples (Supplemental Figure S1). This cut-off was chosen to maximize the 
number of EV-linked miRNAs examined while retaining a large enough sample to assess the 
associations (at least 20 individuals), while removing those EV-linked miRNAs that had a 
very large missing rate. Standard descriptive statistics were used to explore the 
characteristics of the study participants and exposure data. Spearman’s correlation 
coefficients were used to examine correlations between covariates and exposure variables.
EV-linked miRNA-by-EV-linked miRNA Regression Analysis: Linear regression 
models were performed to elucidate top hit EV-linked miRNAs. Models were adjusted for 
continuous age (years), continuous BMI, categorical smoking status, binary race/nationality, 
binary batch, and continuous SVA surrogate variables, identified by the SVA package in R. 
The SVA package can help identify and remove any batch effects or unwanted sources of 
variation, seasonal, meteorological, exposure, or technical variables, which are unknown but 
might be differently distributed in the two batches of samples. It creates surrogate variables, 
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accounting for the unmeasured variation, that act as covariates in our models that would 
account for any unknown, un-modeled, or other sources of (42, 43). EV-linked miRNA 
outcomes were inverse normally transformed to ensure normality with a standard deviation 
of 1. To account for multiple-testing, we applied the Benjamini-Hochberg FDR “p.adjust” 
function in R (44). All statistical analyses were performed in R-version 3.4.0 (45). Statistical 
significance was set at a p-value < 0.05. We used the Benjamini-Hochberg False-Discovery 
Rate (FDR) (44) to account for multiple testing and chose a threshold, FDR q-value < 0.05.
Principal Component Analysis: Principal component analyses (PCA) were performed 
to examine the overall variation of EV-linked miRNA profiles. All of the selected 192 EV-
linked miRNAs were included in the analysis. The function “prcomp” in R was used to 
calculate the principal components (PCs) and the PC loadings for each component. All 
variables were scaled and centered with a mean of 0 and a standard deviation of 1 prior to 
the PCA. PCs were inverse normally transformed for normality. Separate unadjusted 
univariate analyses were performed on age, smoking status, and BMI using linear regression 
with each principal component as the outcome. Mutually adjusted linear regressions were 
performed with the principal components as the outcomes and adjusted for age, BMI, 
smoking status, race, batch, and SVA surrogate variables. Absolute values of the PC 
loadings were taken and the EV-linked miRNAs that contributed a loading in the 90th 
percentile or higher were examined further. This threshold was chosen based on both the 
histogram distribution of the absolute values of the PC loadings (Supplemental Figure S3) 
and the percentile cutoffs (Supplemental Table S5). This would allow us to examine those 
EV-linked miRNAs that are the most important to the principal component while keeping 
the number of EV-linked miRNAs manageable.
Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway Analysis:
An in-silico analysis using a web-based tool, miRWalk2.0 (http://mirwalk.umm.uni-
heidelberg.de/) was performed to investigate gene targets of EV-linked miRNAs (46). Target 
predictions included a comparative analysis of seven prediction programs: DIANAmT, 
miRanda, miRDB, miRWalk, PICTAR5, RNA22, and Targetscan. To decrease the number of 
false positive pathways, targeted genes were identified that were validated in a total of five 
prediction programs including Targetscan and any combination of at least four of the other 
prediction programs. The predicted target search examined promoter, 5’-untranslated 
regions, 3’-untranslated regions, and coding sequences and included a minimum seed length 
of 7 nucleotides (46). Using the genes selected by miRWalk, we ran a Kyoto Encyclopedia 
of Genes and Genomes (KEGG) pathway enrichment analysis using the web-based tool 
DAVID (https://david.ncifcrf.gov/summary.jsp) (47, 48). We restricted our results to only 
those with 10 or more genes listed in the in silico predicted targets and an FDR q-value < 
0.05.
Results:
Study Population
This study consisted of 133 women, mainly Caucasians (92%), while the other 8% consisted 
of women from other ethnicities (Asian, African, and Hispanic). On average, the women in 
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our study were 30.9 ± 3.7 years of age (mean ± standard deviation), had a BMI of 23.6 ± 4.7 
kg/m2, and 9.4 ± 5.1 oocytes retrieved during the IVF cycle (Table 1). The majority of 
women were never smokers (54%) and 26% were current smokers. Most of the women were 
attempting IVF for the first time (65%).
Profile of EV-linked miRNAs in follicular fluid
We screened for EV-linked miRNAs from a panel of 754 microRNAs in follicular fluid 
samples collected from follicles that contained mature oocytes. We detected a signal for 320 
EV-linked miRNAs in at least one of the 133 follicular fluid samples analyzed. Of these, 192 
EV-linked miRNAs met our pre-determined threshold for inclusion and were therefore 
considered as expressed. A list of the selected EV-linked miRNAs with their percent 
expression levels are provided in Supplemental Table S1.
Associations between Body Mass Index and EV-linked miRNA expression in follicular fluid
Possible associations between follicular fluid EV-linked miRNAs and BMI were investigated 
using regression for each EV-linked miRNA. Models adjusted for age, smoking status, race, 
batch, and SVA surrogate variables and modeled BMI continuously. Eighteen EV-linked 
miRNAs were marginally significantly associated with BMI (p < 0.05) (Table 2 and 
Supplemental Table S2) and after adjusting for multiple testing, hsa-miR-328 remained 
significant. A one unit increase in BMI was associated with an increase of hsa-miR-328 
expression value (ΔCt) in 0.03 standard deviation [95% CI: 0.02, 0.05; q-value: 0.03].
Using PCA to examine global variability of EV-linked miRNA profile
Global variability of EV-linked miRNAs was explored using PCA, which revealed that the 
first three PCs explained over 50% of the variability in the outcome data set (PC1: 40%, 
PC2: 6%, PC3: 5%) (Supplemental Figure S2). No associations were identified between 
smoking status, BMI, and age with these PCs in unadjusted univariate analyses; however, 
mutually adjusted models identified PC1 to be significantly associated with BMI (p-value: 
0.01) (Supplemental Table S3). This association remained significant after FDR (q-value: 
0.04). To further examine the makeup of PC1, the absolute values of the PC loadings were 
examined (Supplemental Figure S3 and Supplemental Table S4). Twenty-five EV-linked 
miRNAs in PC1 with a PC loading in the 90th percentile or higher (90th percentile threshold 
> 0.10) were identified. Six EV-linked miRNAs were identified in both the top 25 EV-linked 
miRNAs from PC1 and the 18 top EV-linked miRNAs from the BMI analyses (Figure 2).
In Silico KEGG Pathways analyses
KEGG Pathways of EV-linked miRNAs associated with BMI—We performed two 
KEGG analysis with these EV-linked miRNAs associated with BMI. The first examined the 
18 EV-linked miRNAs that were associated with BMI in the EV-linked miRNA-by-EV-
linked miRNA analysis. For this analysis, the miRWalk tool recognized 1872 unique genes 
that were predicted from at least four prediction programs and the TargetScan software. The 
DAVID software identified 18 FDR significant KEGG pathways that were associated with 
unique genes related to these EV-linked miRNAs. Twelve of these identified KEGG 
pathways are related to oocyte and follicle development and maturation (Figure 1).
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The second BMI KEGG analysis examined the 25 EV-linked miRNAs having a PC loading 
in the 90th percentile or above in PC1. The miRWalk software recognized 4092 unique genes 
and the DAVID software found 43 KEGG pathways significantly associated with these 4092 
genes (q-value < 0.05). Among these 43 KEGG pathways, 24 were involved with biological 
processes of interest to our study (Figure 1).
Discussion:
In the present study, we identified 18 EV-linked miRNAs associated with BMI. Of those, 
only hsa-miR-328 remained statistically significant after FDR-adjustment. Additionally, 
principal component analysis was applied to examine the global variability in the profile of 
192 EV-linked miRNAs. The first principal component explained 40% of the variability in 
the EV-linked miRNA dataset and was significantly associated with an increased BMI in a 
mutually adjusted model.
It has been well established that an increased BMI is associated with decreased fertility 
outcomes, such as reduced pregnancy and fertilization rates (10-12, 49). We found hsa-
miR-328 was significantly associated with BMI after adjusting for covariates and taking into 
account multiple testing. Further examination of hsa-miR-328 identified associations with 
cancer (50, 51). MiR-328 has been known to play a role in myocardial infarction and 
cancers in adults, where obesity is an established risk factor (52). A study examining 
childhood obesity and circulating miRNAs found circulating concentrations of hsa-miR-328 
were higher in obese compared to lean children (53). This suggests that hsa-miR-328 might 
play a role in adipose regulation, obesity, and obesity related diseases. A rodent study found 
that reducing expression of miR-328 blocked pre-adipocyte commitment and inducing 
miR-328 instigated differentiation of brown adipose tissue (54).
Few studies have examined the underlying molecular mechanisms linking BMI with fertility. 
One previous study assessed the associations between circulating plasma microRNAs and 
BMI and found 19 significant microRNAs, including hsa-miR-193b-3p (55). This was the 
only overlapping EV-linked miRNA with our analysis, but the directionality of the 
association with hsa-miR-193b-3p was the opposite of that previously reported (55). 
Another study examined pre-pregnancy BMI and circulating miRNAs during pregnancy and 
identified 27 significant miRNAs in two separate cohorts. Specifically, hsa-miR-28-5p, hsa-
miR-376a, has-miR-139-5p, and hsa-miR-423-5p were found to overlap with those EV-
linked miRNAs which were significantly associated with BMI in our analysis (56). Even 
more EV-linked miRNAs overlapped with Enquobahrie et al, however, the direction of 
association was not consistent for hsa-miR-376a and hsa-miR-139-5p (56).
We also examined whether the global variability of EV-linked miRNAs were associated with 
BMI. EV-linked miRNAs can come from different non-coding sequences but can target the 
same messenger RNA transcripts (57). Thus, one EV-linked miRNA can interfere with the 
expression of many genes and that one gene can be negatively regulated or silenced by many 
EV-linked miRNAs. Our PCA identified principal components that would explain a certain 
percentage of the variability within our EV-linked miRNA dataset and found PC1 was 
significantly associated with BMI. This suggests that the biological variability captured by 
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PC1 was significantly associated with BMI. From these two analyses, six EV-linked 
miRNAs overlapped as significant, hsa-miR-99b, hsa-miR-29a, hsa-miR-28, hsa-miR-328, 
hsa-miR-152, and hsa-miR-331. The EV-linked miRNA that was FDR significant in the EV-
linked miRNA by EV-linked miRNA analysis, hsa-miR-328, was identified as significant in 
both analyses. This suggests that this hsa-miR-328 might be an important EV-linked miRNA 
that could be impacted by an increase in BMI.
Our KEGG pathway analysis of the top EV-linked miRNAs contributing to PC1 revealed 
several pathways associated with pathways of cellular signaling, follicular growth, oocyte 
maturation (58-62). We also performed KEGG pathway analyses on the 18 EV-linked 
miRNAs associated with BMI in the EV-linked miRNA-by-EV-linked miRNA regression 
analyses. We identified 16 significant pathways that overlapped between the three KEGG 
analyses. Eleven of these were associated with oocyte and follicle maturation and 
development: ECM-receptor interaction, focal adhesion, FoxO signaling, oocyte meiosis, 
PI3K-Akt signaling, adipocytokine signaling, AMPK signaling, cGMP-PKG signaling, 
ErbB signaling, gap junction, and GnRH signaling pathways.
These 11 aforementioned pathways contribute to oocyte development, maturation, and 
signaling. More notably the Pl3K-Akt pathway has been associated with recruitment of 
primordial follicles, granulosa proliferation, and ovarian function (63). It also activates the 
mTOR and FoxO pathways (64). The FoxO pathway plays an important role in intra-oocyte 
signaling and can negatively regulate oocyte growth and follicular development by acting as 
a regulatory switch to initiate primordial follicle activation (65-68). The pathway of oocyte 
maturation is induced to transform an immature oocyte into a mature or fertilizable egg (69). 
ECM-receptor interaction (extracellular matrix) is believed to play an essential role in 
regulating follicle development (70) and significantly contributes to follicle 
microenvironments that allow intracellular communication to occur between cells and the 
oocyte (70). Focal adhesion is necessary to establish or maintain the oocyte-granulosa cell 
contact in the follicle (71). Pathways identified by the significant EV-linked miRNAs play 
major roles in follicle and oocyte development and maturation, suggesting that BMI could 
disrupt these processes. This could provide a mechanistic explanation for the reduced 
fertility rates and increased spontaneous abortion rates that are observed with an increased 
BMI.
This study has limitations. First, we quantified EV-linked miRNA profiles from a single 
follicle, it might not accurately represent the EV-linked miRNA profile of the whole cohort 
of follicles. In a previous analysis (unpublished data) we compared the profile of EV-linked 
miRNA from two follicles per patients that contained mature oocytes, and their profiles were 
highly correlated. As the single follicle did not always contain the oocyte that yielded the 
embryo that was transferred and in many of the cases more than one embryo was transferred, 
we were limited in testing associations of BMI, EV-linked BMI and pregnancy outcomes. 
Second, we ran our KEGG pathway analyses on a relatively small number of EV-linked 
miRNAs. Thus, our results may be subject to overfitting of the selected pathways by the 
software. To minimize this, we set our inclusion of genes to those found in at least four 
separate prediction software packages in addition to the Target scan database. We also 
included those EV-linked miRNAs that were marginally significant but did not meet the 
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FDR threshold for multiple comparisons. EV-linked miRNAs are highly correlated and have 
high biological variability between samples, so to prioritize biological relevance in our 
pathway analyses we chose to include all those EV-linked miRNAs that met the marginally 
significant threshold (p < 0.05). In addition, while we can assure that we have a pellet 
enriched in EVs, it is possible that the pellet included not only miRNAs that are 
encapsulated within the EV, but also miRNAs that were extracellularly attached to EVs (28). 
Additionally, there is a possibility that some of the miRNAs in the pellet derived either from 
necrotic cells (28, 72). To ensure we extract EV-linked miRNAs, we have optimized our 
protocol by running thousands of samples in previous large studies investigating EV-linked 
miRNAs as well as assessed random follicular fluid samples by Nanosight and flow 
cytometry.
Our study has significant strengths as well. First, to our knowledge, this is the first study to 
examine BMI with respect to EV-linked miRNAs in follicular fluid. Second, we used PCA 
to examine how EV-linked miRNAs contribute to variability in our dataset, allowing us not 
only to expand upon work done by others, but also to examine the global variability of the 
outcomes.
In conclusion, these identified associations between an increased BMI and follicular fluid 
EV-linked miRNAs may provide an insight as to how higher BMI may disrupt fertility on a 
mechanistic level.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Venn diagram of EV-linked miRNAs identified in linear models and PCA.
Venn diagram of EV-linked miRNAs identified in the linear regression models and principal 
component analysis. Red EV-linked miRNAs represent the top identified EV-linked miRNAs 
associated with the 90th percentile of PC1 loadings. Blue EV-linked miRNAs represent those 
EV-linked miRNAs that were found to be marginally significant in linear models (p < 0.05).
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Figure 2. Venn diagram of FDR significant KEGG pathways.
Venn diagram of FDR significant KEGG pathways identified from KEGG analyses. Red 
pathways represent those KEGG pathways identified with EV-linked miRNAs associated 
with the 90th percentile of PC1 loadings. Blue pathways represent those KEGG pathways 
that were associated with EV-linked miRNAs and BMI. Bolded pathways indicate a KEGG 
pathway associated with oocyte or follicle maturation, development, or fertilization.
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Table 1.
Patients’ demographic characters (N= 133)
Age, years 30.9 ± 3.7
BMI, kg/m2 23.6 ± 4.7
Number of oocytes retrieved 9.4 ± 5.1
WHO BMI categories Underweight 15 (11%)
Normal 73 (56%)
Overweight 31 (23%)
Obese 14 (10%)
Smoking Status Never Smoker 72 (54%)
Ever Smoker 27 (20%)
Current Smoker 34 (26%)
IVF attempts First IVF Attempt 87 (65%)
IVF Attempt > 1 46 (35%)
Ethnicity Caucasian 122 (92%)
Asian 8 (6%)
African 1 (1%)
Hispanic 2 (1%)
Diagnosis PGD 57 (43%)
Male Factor 53 (40%)
Unexplained 20 (15%)
Othera 3 (2%)
Pre-IVF Fertility Status Fertile 58 (44%)
Infertile 75 (56%)
Values represent: mean ± SD or number (%)
Abbreviations: BMI - Body mass index, SD - Standard Deviation, IVF - In Vitro Fertilization, PGD - Pre-gestational diagnosis
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Table 2.
P-value significant EV-linked miRNAs associated with Body Mass Index and Top FDR Significant EV-linked 
miRNA c
EV-linked miRNA
Name
% Expressed in
Population (# of
samples) Effect Size 
b 95% Confidence
Interval
Unadjusted
p-value
FDR
q-value a
hsa-miR-328 ** 100% (n = 133) 0.032 [0.016, 0.048] < 0.001 0.03
hsa-miR-1290 51% (n = 67) 0.049 [0.016, 0.081] 0.004 0.3
hsa-miR-193b-3p 100% (n = 133) 0.03 [0.008, 0.051] 0.01 0.3
hsa-miR-193b-5p 52% (n = 69) 0.035 [0.009 0.061] 0.01 0.3
hsa-miR-29a 93% (n = 123) 0.018 [0.005, 0.032] 0.01 0.3
hsa-miR-99b 100% (n = 133) 0.017 [0.004, 0.031] 0.01 0.3
hsa-miR-331 100% (n = 133) 0.017 [0.004, 0.031] 0.01 0.3
hsa-miR-423-5p 69% (n = 91) 0.028 [0.005, 0.052] 0.02 0.39
hsa-miR-320a 100% (n = 133) 0.022 [0.003, 0.040] 0.02 0.46
hsa-miR-720 98% (n = 130) 0.028 [0.003, 0.054] 0.03 0.5
hsa-miR-28 99% (n = 131) 0.017 [0.001, 0.032] 0.03 0.5
hsa-miR-483-5p 100% (n = 133) 0.027 [0.002, 0.052] 0.03 0.5
hsa-miR-152 89% (n = 118) 0.018 [0.001, 0.035] 0.03 0.5
hsa-miR-376a 95% (n = 126) −0.023 [−0.045, −0.001] 0.04 0.5
hsa-miR-376c 84% (n = 111) −0.023 [−0.046, −0.001] 0.04 0.5
hsa-miR-1274B 100% (n = 133) 0.026 [0.001, 0.051] 0.04 0.5
hsa-miR-184 53% (n = 70) 0.023 [0.000, 0.047] 0.05 0.51
hsa-miR-139-5p 71% (n = 94) −0.024 [−0.049, 0.000] 0.05 0.51
**
FDR significant EV-linked miRNA, after adjusting for multiple testing
a
FDR q-value adjusted for multiple testing for the 192 EV-linked miRNAs
b
For every one unit increase in BMI, there is an effect size increase/decrease in standard deviation of EV-linked miRNA ΔCt, with a lower ΔCt 
indicates higher expression
c
Models were adjusting for age, smoking status, ethnicity, batch, and SVA surrogate variables
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